Blue-Zone Technologies recognized for sustainability and for contributing to the reduction of greenhouse gasses.
TORONTO, ON – November 20, 2023 – Blue-Zone Technologies Ltd. (“Blue-Zone”), a Canadian cleantech pharmaceutical company that leverages globally patented technology to capture and convert waste anesthetic gases (WAGs) from healthcare facilities, has been awarded the Sustainability Leadership Award by the Business Intelligence Group. The award was presented as part of the 2023 Sustainability Awards program, which recognizes companies that have made sustainability an integral part of their business practice or overall mission.
Blue-Zone’s innovative technology is solving a significant global climate issue by capturing and converting waste anesthetic gases (WAGs) from healthcare facilities into a sustainable and cost-efficient source of inhalation anesthetic drugs. The healthcare industry is responsible for a significant portion of greenhouse gas emissions due to the use of anesthetic gases, which are potent contributors to climate change. Blue-Zone’s approach is a significant step towards reducing hazardous environmental waste and promoting sustainability in the healthcare industry.
The Sustainability Awards recognize companies that have made sustainability an integral part of their business practice. Judged by a panel of experts in the field of environmental impact, the awards offer increased exposure for the exemplary accomplishments of leaders, initiatives, and organizations working to reduce the impact of their business on the environment.
“We are thrilled to receive this award from the Business Intelligence Group. At Blue-Zone, we are committed to developing sustainable solutions to reduce hazardous environmental waste and promote sustainability in healthcare,” said Kipton Lade, CEO of Blue-Zone Technologies.
“At Blue-Zone, sustainability is not just an initiative, but rather an integral part of our culture. This recognition is a testament to our team’s unwavering commitment and dedication to our mission of promoting sustainable anesthetic recovery for healthcare institutions. We believe that our innovative technology can make a significantly positive impact on our society and for the environment.”
About Blue-Zone Technologies Ltd.
Headquartered in Toronto, Ontario, Canada, Blue-Zone’s mission is to reduce hazardous environmental waste in healthcare facilities and lower financial costs by applying Blue-Zone’s patented technology. Blue-Zone collects unused anesthetics that would normally be vented into the environment and processes the collected material into its pure form providing a sustainable and cost-efficient source of inhalation anesthetic drugs. As such, Blue-Zone is the world’s first Cleantech Pharmaceutical Company, running a fully operational, GMP compliant, Health Canada licensed Drug Establishment Facility for Anesthetic Recovery, Raw Material and Final Product Production. For more information visit www.blue-zone.com.
For more information, contact: Media Inquiries:
Kipton Lade, CEO, Blue-Zone Technologies
Jennifer Lee, RP Pelican